Endoscopy Sales Growth to Support BSX Stock Amid Fierce Competition

Boston Scientific (BSX) is gaining from new product launches and accretive acquisitions. Yet, unfavorable currency movement and macroeconomic concerns are major dampeners. The stock carries a Zacks Rank #3 (Hold) currently.Factors Driving BSX SharesBoston Scientific’s Endoscopy business within MedSurg is gaining from strong worldwide demand for its broad range of gastrointestinal and pulmonary treatment options. Particularly, the company is gaining market share, driven by the above-market growth of AXIOS an ...